recombinant human IL-2

interleukin-2

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for recombinant human IL-2, covering 2024-02-26 to 2024-02-26. Get the full timeline:

Most recent: Clinical Trial Update: Low-dose Recombinant Human IL-2 for the Treatment of Relapsing Polychondritis [Phase 2]